Deanna Kroetz
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome …
SS Lee, T Pineau, J Drago, EJ Lee, JW Owens, DL Kroetz, ...
Molecular and cellular biology 15 (6), 3012-3022, 1995
18601995
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C> T affects mRNA stability
D Wang, AD Johnson, AC Papp, DL Kroetz, W Sadee
Pharmacogenetics and genomics 15 (10), 693-704, 2005
5862005
Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10, 11-epoxide formation
BM Kerr, KE Thummel, CJ Wurden, SM Klein, DL Kroetz, FJ Gonzalez, ...
Biochemical pharmacology 47 (11), 1969-1979, 1994
5301994
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
Z Yu, F Xu, LM Huse, C Morisseau, AJ Draper, JW Newman, C Parker, ...
Circulation research 87 (11), 992-998, 2000
5152000
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
DL Kroetz, C Pauli-Magnus, LM Hodges, CC Huang, M Kawamoto, ...
Pharmacogenetics and Genomics 13 (8), 481-494, 2003
4712003
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)
LM Hodges, SM Markova, LW Chinn, JM Gow, DL Kroetz, TE Klein, ...
Pharmacogenetics and genomics 21 (3), 152, 2011
3712011
The pharmacogenetics research network: from SNP discovery to clinical drug response
KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...
Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007
2822007
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints
MK Leabman, CC Huang, J DeYoung, EJ Carlson, TR Taylor, ...
Proceedings of the National Academy of Sciences 100 (10), 5896-5901, 2003
2552003
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics
F Innocenti, DL Kroetz, E Schuetz, ME Dolan, J Ramírez, M Relling, ...
Journal of Clinical Oncology 27 (16), 2604, 2009
2522009
Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes
DL Kroetz, P Yook, P Costet, P Bianchi, T Pineau
Journal of Biological Chemistry 273 (47), 31581-31589, 1998
2511998
Cytochrome P450 pathways of arachidonic acid metabolism
DL Kroetz, DC Zeldin
Current opinion in lipidology 13 (3), 273-283, 2002
2332002
Adherence-resistance relationships to combination HIV antiretroviral therapy
DR Bangsberg, DL Kroetz, SG Deeks
Current HIV/AIDS Reports 4 (2), 65-72, 2007
2112007
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing
MA Martin, TE Klein, BJ Dong, M Pirmohamed, DW Haas, DL Kroetz
Clinical Pharmacology & Therapeutics 91 (4), 734-738, 2012
1862012
Irinotecan‐induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein
FA De Jong, TJ Scott‐Horton, DL Kroetz, HL McLeod, LE Friberg, ...
Clinical Pharmacology & Therapeutics 81 (1), 42-49, 2007
1842007
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101
RM Baldwin, K Owzar, H Zembutsu, A Chhibber, M Kubo, C Jiang, ...
Clinical Cancer Research 18 (18), 5099-5109, 2012
1832012
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa
S Parikh, JB Ouedraogo, JA Goldstein, PJ Rosenthal, DL Kroetz
Clinical Pharmacology & Therapeutics 82 (2), 197-203, 2007
1762007
Evolutionary conservation of vertebrate blood–brain barrier chemoprotective mechanisms in Drosophila
F Mayer, N Mayer, L Chinn, RL Pinsonneault, D Kroetz, RJ Bainton
Journal of Neuroscience 29 (11), 3538-3550, 2009
1652009
The effects of a diet rich in docosahexaenoic acid on organ and vascular fatty acid composition in spontaneously hypertensive rats
MM Engler, MB Engler, DL Kroetz, KDB Boswell, E Neeley, SM Krassner
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 61 (5), 289-295, 1999
1651999
Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR
P Su, KM Kaushal, DL Kroetz
American Journal of Physiology-Regulatory, Integrative and Comparative …, 1998
1641998
ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise
LW Chinn, DL Kroetz
Clinical Pharmacology & Therapeutics 81 (2), 265-269, 2007
1632007
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20